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In this issue of Cell Stem Cell, Kiel et al. (2007) demonstrate that N-cadherin is not expressed on
repopulating hematopoietic stem cells (HSCs) and that reduction of osteoblasts does not affect
HSC frequency, suggesting that other molecular pathways may also modulate the interaction of
HSCs with their niches.Within the bone marrow (BM) micro-
environment, hematopoietic stem cells
(HSCs) reside in proximity to osteo-
blastic, vascular, and stromal cells,
where they maintain a predominantly
quiescent state, undergo self-renewal,
and are recruited to reconstitute he-
matopoiesis (Adams et al., 2006; Calvi
et al., 2003; Heissig et al., 2002; Kiel
et al., 2005; Zhang et al., 2003). Given
the technical hurdles associated with
isolating and tracking long-term repo-
pulating HSCs within the BM, the
molecular and cellular pathways that
mediate interaction of true HSCs with
their niches have been difficult to
study. Utilizing immunoselection ap-
proaches, it has been proposed that
homotypic N-cadherin-mediated in-
teractions between phenotypically
marked N-cadherin+ HSCs and N-
cadherin+ osteoblasts support long-
term maintenance of HSCs (Zhang
et al., 2003). However, in the current is-
sue, Kiel et al. have used genetic track-
ing tomark N-cadherin expression and
demonstrate that N-cadherin is not
expressed on long-term repopulating
HSCs. In addition, reduction of osteo-
blasts in this system does not affect
the number of HSCs in BM. These
data point to the complexity of deci-
phering the molecular pathways that
regulate interaction of the repopulating
HSCs with their niches, and suggest
that other as of yet unrecognized ad-
hesion molecules and chemokines
may also participate in the interaction
of HSCs with their niches.
Reconstitution and maintenance of
hematopoiesis are dependent notonly on cell intrinsic properties of
HSCs, but also on extrinsic, dynamic
interactions of HSCs with their niches.
A ‘‘stem cell niche’’ is defined as
a highly specialized microenvironment
that preserves a balance between qui-
escence and self-renewal of HSCs by
interactions with stromal cells, such
as endosteal cells (osteoblastic niche)
or vascular cells (vascular niche) (Fig-
ure 1). However, the precise anatomi-
cal location of the HSC niche has
dodged precise definition mainly due
to technical barriers of working with
calcified boney tissues and the non-
static nature of the hematopoietic sys-
tem. Heissig et al. demonstrated that
after myelosuppression, hematopoi-
etic recovery was initiated in the oste-
oblastic followed by vascular niches
(Heissig et al., 2002). The delay in he-
matopoietic recovery of the vascular
niche was due to rapid regression of
endothelial cells, as these cells are
more susceptible to myeloablative in-
sults (Kopp et al., 2005). Subse-
quently, it was demonstrated that a
hormonally induced increase in the
number of osteoblasts correlated
with a modest increase in the number
of HSCs (Calvi et al., 2003). N-cadherin
was also shown to be expressed on
10% of the Sca1+cKit+lin hemato-
poietic cells, supporting the notion
that homotypic N-cadherin interaction
with osteoblasts is critical for main-
tenance of phenotypically marked
HSCs (Zhang et al., 2003). However,
from these studies it was unclear
whether N-cadherin was indeed ex-
pressed on authentic repopulatingCell Stem CelHSCs or whether N-cadherin is neces-
sary for osteoblastic regulation of HSC
homeostasis.
To answer these questions, Kiel
et al. using both immunoselection
methods and genetic tracking of N-
cadherin+ hematopoietic cells, show
that N-cadherin is not expressed on
long-term repopulating HSCs. Using
commercially available antibodies to
N-cadherin, Kiel et al. did not detect
HSC activity in the N-cadherin+ frac-
tion of BM cells. Importantly, only N-
cadherin BM populations could re-
constitute long-term hematopoiesis
in lethally irradiated mice. To eliminate
the possibility that N-cadherin expres-
sion affects homing in vivo, the authors
found that N-cadherin+ fractions had
little progenitor capacity in an in vitro
colony assay, suggesting that N-
cadherin may not mark a population
of primitive hematopoietic cells.
More convincingly, Kiel et al. utilized
the N-cadherinlacZ gene trap mice, in
which the endogenous promoter
of N-cadherin drives the expression
of lacZ (Luo et al., 2005), in order
to formally prove that phenotypi-
cally marked Sca1+cKit+linFlk2
andCD150+CD48CD41cKit+Sca1+lin
HSCs lack the expression of
N-cadherin. To address whether N-
cadherin expression is upregulated
only during physiological stress, Kiel
et al. demonstrated that even after
myelosuppression, N-cadherin ex-
pression was undetectable on mobi-
lized HSCs. It is conceivable that in
N-cadherinlacZ gene trap mice the ex-
pression of N-cadherin is aberrantlyl 1, August 2007 ª2007 Elsevier Inc. 127
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cause Kiel et al. demonstrated that
N-cadherin expression follows the
reported expression pattern in other
tissues.
How, then, can one reconcile the
differing findings of the impact of N-
cadherin expression on HSC function?
Might N-cadherin detection be incon-
sistent due to technical differences of
FDG-dependent cell sorting of N-
cadherin-lacZ+ cells, or to antibodies
with varying affinities directed against
protease-sensitive N-cadherin epi-
topes? In addition, analysis of diverse
populationsofHSCs (Sca1+lincKit+-SP
and Sca1+lincKit+Flk2, versus
SLAM+Sca1+lincKit+) and technical
hurdles associated with the process-
ing of BM (i.e., use of collagenase
versus marrow burrowing) may also
contribute to the discrepancies in
the detection of N-cadherin on true
HSCs. Notwithstanding, the ultimate
proof of the role of N-cadherin in
the regulation of hematopoiesis may
emerge from studies in which the
expression of N-cadherin is condi-
tionally knocked out in the HSCs,
or their progeny, and/or osteoblastic
cells. This approach requires gener-
ation of a floxed N-cadherin allele,
as homozygous N-cadherin-deficient
mice do not survive. Until then, the
role of N-cadherin homotypic inter-
action of HSCs with osteoblastic
cells necessitates further experimen-
tation, including generation of more
specific reagents to detect functional
N-cadherin.
Figure 1. Interaction of HSCs with Osteoblastic and Vascular Niches
Within the BMmicroenvironment, phenotypically marked HSCs have been shown to be positioned
within the vicinity of the endosteal zone (osteoblastic niche) and sinusoidal endothelial cells (vas-
cular niche). While the osteoblastic niche may provide a safe haven for the maintenance and self-
renewal of HSCs, BM’s vascular niche may also set up a cellular platform for the reconstitution of
hematopoiesis and directing the trafficking of HSCs and their progeny. However, whether true
long-term repopulating HSCs are tethered to the osteoblastic niche through homotypic N-
cadherin interaction requires further rigorous analysis. It is possible that under certain physiolog-
ical conditions subsets of true repopulating HSCs may indeed interact with specific subset oste-
oblastic cells through an N-cadherin homotypic engagement. The mechanism by which HSCs
crosstalk with the vascular niche is also not fully defined. There is no doubt that other as of yet
unrecognized cytokines, chemokines, and adhesion molecules contribute to the complex interac-
tion of the true HSCs with their niches.128 Cell Stem Cell 1, August 2007 ª2007 Elsevier Inc.Another concept explored by Kiel
et al. is the role of osteoblasts in mod-
ulating HSC proliferative capacity. An
increase in the number of osteoblasts
has been shown to augment the num-
ber of HSCs (Adams et al., 2006; Calvi
et al., 2003). However, as it is techni-
cally difficult to isolate putative HSCs
directly from the osteoblastic niche
and evaluate their stem cell activity, it
has been unclear to what extent osteo-
blasts increase the numbers of true
HSCs. Kiel et al. took advantage of
a genetic model of biglycan deficiency
to reduce osteoblast number and
found no effects on HSC pools, sug-
gesting that osteoblasts may not
directly influence the size of HSC
population. It is possible that in the
biglycan-deficient mice, the number
of osteoblasts were not sufficiently de-
creased to affect frequency of the
HSCs. Indeed, near complete ablation
of osteoblasts in adult mice results in
impaired reconstitution of hematopoi-
esis (Visnjic et al., 2004). However,
Kiel et al. show that the majority of
phenotypically marked HSCs were
not localized to osteoblasts, but nearly
60% of putative HSCs were detected
in the vicinity of the BM’s sinusoidal
vessels (Kiel et al., 2005). These data
suggest that multidimensional interac-
tion of true HSCswith osteoblastic and
vascular niches, and perhaps as yet
unrecognized stromal cells, may be
necessary for the HSC maintenance.
This also raises the intriguing possi-
bility that endosteal cells regulate HSC
function indirectly by regulating the in-
tegrity of the vasculature in the BM and
vice versa. To this end, development
of models to selectively target osteo-
blastic, vascular, or BM stromal cells
is essential to interrogate the autono-
mous role of these complex niches in
the regulation trafficking, self-renewal,
and maintenance of HSCs. For
example, selective ablation of the
vascular niche abrogates megakaryo-
cytopoiesis, since interaction of mega-
karyocytic progenitors with the BM’s
sinusoidal vessels is essential for
thrombopoiesis (Avecilla et al., 2004).
However, targeting the osteoblastic
niche without affecting the vascular
niche is cumbersome, since osteo-
blast-derived angiogenic factors may
modulate establishment of the vascular
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identification of molecular markers to
track the itinerary of a true HSC within
theBM in real time is necessary in order
to eavesdrop on the subtle molecular
conversations betweenHSCsand their
dynamic niches.
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ogy revolve around the origin, tissue
home, and physiological role of the
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been identified over the past several
decades. For some, such as hemato-
poietic and epidermal stem cells, their
niches and biological roles are rela-
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ning to understand their importance
in the adult organism. And for yet
others, we still know little. Among this
latter group are mesenchymal stem
cells (MSCs), which, while intensively
studied in culture, have remained
elusive with regard to their in vivo biol-
ogy. In this regard, a recent paper in
Cell by Takashima et al. (2007) has
addressed the in vivo biology of
MSCs, with some surprising and unex-
pected conclusions.
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as clones and to differentiate into
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cytes (Prockop, 1997). Subsequent
work defined markers that enabled
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thos et al., 1994; Pittenger et al.,
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their utility for a number of cell-
replacement applications (Deans and
Moseley, 2000; Horwitz et al., 2002).
However, we still know little about their
in vivo biology. For example, what is
the niche(s) for MSCs in adult tissues?
What role do MSCs play in tissue
turnover and/or in response to injury?
Where do MSCs come from? It is this
final question that is the subject of
the paper by Takashima et al. (2007).
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derive from two developmental ori-
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derm (Dennis and Charbord, 2002).
Takashima et al. (2007) therefore
chose to ask how MSCs arise, initially
by studying ES cells. Using protocols
that differentiate ES cells to mesoder-
mal versus neural/neural crest line-
ages, they demonstrated that both
lineages generated PDGFRa-positive
cells (a marker for MSCs) that could
make adipocytes. However, the sur-
prise came when they found that the
neural, but not mesodermal, differenti-
ations contained MSCs that could
proliferate extensively as multipotent
clones. Moreover, these MSCs were
generated from cells expressing
Sox1, a definitive marker for neuroepi-
thelium, demonstrating their neural
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